| Trial ID: | L0086 |
| Source ID: | NCT00303537
|
| Associated Drug: |
Metformin
|
| Title: |
Metformin in Non-Alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver
|
| Interventions: |
Drug: metformin
|
| Outcome Measures: |
Grade of steatosis as judged by repeat biopsy|Grade of necroinflammation as judged by repeat biopsy|Liver density obtained by computer scan|Serum alanine transaminase (ALAT)
|
| Sponsor/Collaborators: |
University Hospital, Aker|Merck Sharp & Dohme Corp.
|
| Gender: |
All
|
| Age: |
20 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
90
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment
|
| Start Date: |
November 2004
|
| Completion Date: |
June 2008
|
| Results First Posted: |
--
|
| Last Update Posted: |
July 2, 2007
|
| Locations: |
Haukeland Universitetssykehus, Bergen, Norway|Aker University Hospital, Oslo, Norway|Akershus University Hospital, Oslo, Norway|Universitetssykehuset i Nord-Norge, Troms??, Norway
|
| URL: |
https://ClinicalTrials.gov/show/NCT00303537
|
